Bogumila Jagiello’s Post

Looking to run a #digitaltherapeutics study? There are a lot of elements that set these studies apart from others. Our latest blog showcases some of the most important factors to consider when designing and implementing a digital therapeutics trial. Read the full article here 👉 https://lnkd.in/enNNgSjh #dtx #clinicaltrials #clinicaltrialdesign

In this K-Cast episode, Diana Brixner, discusses the level of clinical evidence payers should expect and require from non-prescription digital health tools compared to FDA-approved digital therapeutics! Brixner offers insight as to where the biggest gaps in evidence generation for digital therapeutics come from. Watch here: https://bit.ly/4drOvLE #ManagedCare #DigitalHealth

“We have to make the thing we’re bringing to market look more like something that the market understands how to value and how to buy. The market doesn’t understand exactly how to buy and deploy digital therapeutics." Our founder and CEO Aaron Gani recently spoke with STAT's Mario Aguilar about the evolution of RealizedCare and how our new digital care management solution for chronic pain aims to solve notable challenges within the digital therapeutics industry. Read more: https://hubs.la/Q02gYDgC0 #ChronicPain #DigitalCareManagement #DigitalHealth #CareManagement #DigitalTherapeutics

At RealizedCare we've always believed that #digitaltherapeutics will improve access, improve health, and drive attendant savings in healthcare - all vital for improving population health and making our healthcare system sustainable. Digital therapeutics are poised to be one of the most transformative shifts in healthcare - shattering barriers of access and affordability. Read Mario Aguilar's insightful article to get a look at how RealizedCare, Freespira and Akili are evolving our business models to unlock the full value of DTx. (and we are just three examples - learn more at Digital Therapeutics Alliance!) Joseph Perekupka, Eddie Martucci, Andy Molnar

Many people have seen the Calm app on T.V., but what do you know about the apps that are actually FDA cleared and require a prescription? Here is a brief review of those apps cleared for use in mental health disorders. #digitalhealth #pharmacy #USCMann

Exciting insights on China's NRDL 2023! Our article covers the latest developments, from oncology breakthroughs to rare disease triumphs. A must-read for anyone in healthcare. Check it out here: https://ow.ly/2wbS30syXGA #Healthcare #Pharma #Biotech #MarketStrategy #SimonKucher

Exciting insights on China's NRDL 2023! Our article covers the latest developments, from oncology breakthroughs to rare disease triumphs. A must-read for anyone in healthcare. Check it out here: https://ow.ly/NUhi30szl8B #Healthcare #Pharma #Biotech #MarketStrategy #SimonKucher

Struggling with the “Double-blinded placebo-controlled randomized controlled clinical trial for patients with Anal Intraepithelial Neoplasia (AIN),” Frantz Viral Therapeutics, a joint venture between Georgetown University Medical Center and Frantz Medical Group, faced numerous challenges while dealing with the trial phases. Moving ahead, they reached out to us with their concern over the ongoing challenges and sought help through Jeeva Clinical Trials Inc.'s eclinical solutions to accelerate their research. Learn how we accepted the challenges and, through our efficient and innovative solutions, assisted them in fulfilling their objectives from this case study: https://hubs.la/Q02gg2dj0 #RCT #clinicaltrials #AIN #healthtech #casestudy #randomizedclinicaltrial

Wrapping up the 19th Annual HD Therapeutics Conference 2024 with enlightening insights! Here's a brief recap from the final day of the conference. Stay tuned for more updates! #HDResearch #HuntingtonsDisease #ScientificAdvancements #HDAfrica